Pipradrol proved useful for these applications as its relatively mild stimulant effects gave it a good safety profile compared to stronger stimulants. It was also studied as an adjutant treatment for depression and schizophrenia although it was never widely used for these purposes.
Pipradrol proved valuable in these situations because of its mild invigorating effects, which provided it an advantageous safety record relative to stronger energizers. Furthermore, it was examined as a complementary treatment for depression and schizophrenia, although it never achieved broad usage for these conditions.